Keyphrases
Knock
100%
Epstein-Barr Virus
100%
Single-chain Antibody
100%
Latent Membrane Protein 1 (LMP1)
100%
B-cell Lymphoma 2 (Bcl-2)
28%
B Lymphocytes
28%
Immunocompromised Patients
28%
Epstein-Barr Virus-associated Lymphoproliferative Disorder
28%
Novel Treatments
14%
Protein Level
14%
Gene Therapy
14%
Bcl-2 Expression
14%
Transmembrane Protein
14%
Functional Inhibition
14%
Conventional Chemotherapy
14%
Hodgkin Disease
14%
Oncoprotein
14%
Burkitt Lymphoma
14%
Induced Cell Death
14%
Nasopharyngeal Carcinoma
14%
Intracellular Level
14%
Lymphoproliferative Disorders
14%
Mediated Reduction
14%
Endoplasmic Reticulum Targeting
14%
Intracellular Expression
14%
Drug-induced
14%
Medicine and Dentistry
Knock Out
100%
Epstein Barr Virus
100%
Single Chain Fragment Variable Antibody
100%
Latent Membrane Protein 1
100%
B Lymphocyte
28%
Immunocompromised Patient
28%
Virus-Associated Lymphoma
28%
Upregulation
14%
Endoplasmic reticulum
14%
Cell Death
14%
Membrane Protein
14%
Gene Therapy
14%
Hodgkin's Lymphoma
14%
Lymphoproliferative Disease
14%
Oncoprotein
14%
Nasopharynx Carcinoma
14%
Burkitt's Lymphoma
14%
Immunology and Microbiology
Epstein Barr Virus
100%
Single-Chain Variable Fragment
100%
Epstein-Barr Virus Latent Membrane Protein 1
100%
Bcl-2
42%
B Cell
28%
Immunocompromised Patient
28%
Endoplasmic reticulum
14%
Cell Death
14%
Upregulation
14%
Pharmacology, Toxicology and Pharmaceutical Science
Epstein-Barr Virus
100%
Single Chain Fragment Variable Antibody
100%
Epstein-Barr Virus Latent Membrane Protein 1
100%
Immunocompromised Patient
28%
Chemotherapy
14%
Membrane Protein
14%
Hodgkin Disease
14%
Oncoprotein
14%
Lymphoproliferative Disease
14%
Burkitt's Lymphoma
14%
Nasopharynx Carcinoma
14%